Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Bioprinting, Tissue Engineering and Synthetic Biology

James Yoo's Biography



James Yoo, Professor, Associate Director and Chief Scientific Officer, Wake Forest Institute for Regenerative Medicine

Dr. Yoo is a surgeon and researcher. He is currently a Professor, Associate Director and Chief Scientific Officer at the Wake Forest Institute for Regenerative Medicine, and is cross-appointed to the Departments of Physiology and Pharmacology and Biomedical Engineering. Dr. Yoo's research efforts have been directed toward the clinical translation of tissue engineering technologies and cell-based therapies. Dr. Yoo's background in cell biology and medicine has facilitated the transfer of several cell-based technologies from the bench-top to the bedside. A few notable examples of successful clinical translation include the bladder, urethra, vagina, and muscle cell therapy for incontinence. Dr. Yoo has been a lead scientist in the bioprinting program at WFIRM, and has been instrumental in developing skin bioprinting and integrated tissue and organ printing systems for preclinical and clinical applications.

James Yoo Image

Bioprinting for Translational Applications

Thursday, 16 March 2017 at 17:00

Add to Calendar ▼2017-03-16 17:00:002017-03-16 18:00:00Europe/LondonBioprinting for Translational ApplicationsSELECTBIOenquiries@selectbiosciences.com

Tissue engineering and regenerative medicine has emerged as an innovative scientific field that focuses on developing new approaches to repairing cells, tissues and organs. Over the years, various engineering strategies have been developed to build functional tissues and organs for clinical applications. However, challenges still exist in developing complex tissue systems. In recent years, 3D bioprinting has emerged as an innovative tool that enables rapid construction of complex 3D tissue structures with precision. This developing field promises to revolutionize the field of medicine addressing the dire need for tissues and organs suitable for surgical reconstruction. In this session novel and versatile approaches to building tissue structures using 3D printing technology will be discussed. Clinical perspectives unique to 3D printed structures will also be discussed.


Add to Calendar ▼2017-03-16 00:00:002017-03-17 00:00:00Europe/London3D-Bioprinting, Tissue Engineering and Synthetic BiologySELECTBIOenquiries@selectbiosciences.com